China Asks Drugmakers, Hospitals to Find US Import Substitutes

China Asks Drugmakers, Hospitals to Find US Import Substitutes

China has asked some of its state-owned drugmakers to study how they can reduce reliance on the US for pharmaceutical products and raw materials, people familiar with the matter said, as Beijing prepares for a potential decoupling that threatens its medical supply.

China may add joint health support into list of approved claims

China’s State Administration of Market Regulation (SAMR) is considering the addition of joint health support into its 24 approved health claim functions.

China asks drugmakers, hospitals to find US import substitutes

China has asked some of its state-owned drugmakers to study how they can reduce reliance on the US for pharmaceutical products and raw materials, sources familiar with the matter said, as Beijing prepares for a potential decoupling that threatens its medical supply.